A groundbreaking partnership aims to provide low-cost lenacapavir to millions at risk of HIV in low- and middle-income countries, potentially transforming HIV prevention efforts worldwide.
President Trump unveils a groundbreaking executive order aimed at slashing U.S. drug prices by matching them to those in developed countries. Will this initiative reshape the pharmaceutical landscape and benefit American patients?
